BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• Business

  Gentris Corporation Announces Collaboration to Study Blood Stability

  July 27, 2012

   · 

  2 min read
• Pharm Country

  FluoroPharma Announces Milestone for BFPET

  July 27, 2012

   · 

  1 min read
• Policy

  Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceutical Co. Ltd. Announce Filing of Supplemental New Drug Application for AMITIZA (Lubiprostone) in Opioid-induced Constipation

  July 27, 2012

   · 

  1 min read
• Business

  Durata Therapeutics, Inc. Adds Independent Director Lisa M. Giles to the Company’s Board

  July 27, 2012

   · 

  1 min read
• Lone Star Bio

  Retractable Technologies, Inc. Launches New VanishPoint®Blood Collection Set

  July 27, 2012

   · 

  1 min read
• FDA

  Bracco Diagnostics Inc. Receives U.S. FDA Approval for Expanded Labeling of MultiHance® (gadobenate dimeglumine) Injection in Magnetic Resonance Angiography

  July 27, 2012

   · 

  1 min read
• Business

  Watson Pharmaceuticals, Inc. Second Quarter 2012 Non-GAAP Diluted EPS Increases 41% to $1.42; Net Revenue Increases 25% to Over $1.3 Billion

  July 27, 2012

   · 

  1 min read
• Pharm Country

  Neurotez, Inc. Announces Grant of U.S. Patent 8,227,408 Around Its Leptin Therapy for Alzheimer’s Disease

  July 27, 2012

   · 

  1 min read
• Genetown

  InVivo Therapeutics Corporation Announces New Stock Symbol ‘NVIV’

  July 27, 2012

   · 

  1 min read
• Drug Development

  SuppreMol Begins Development of Anti-IL-3 Monoclonal Antibody to Diagnose and Treat Early Stage Rheumatoid Arthritis

  July 27, 2012

   · 

  3 min read